These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1513485)

  • 1. Iron, Parkinson's disease, and neuroleptic malignant syndrome.
    Iwasaki Y; Kinoshita M; Ikeda K; Sugimoto H
    Neurology; 1992 Sep; 42(9):1845. PubMed ID: 1513485
    [No Abstract]   [Full Text] [Related]  

  • 2. Low serum iron and neuroleptic malignant syndrome.
    Garcia FM; Duarte J; Perez A; Mataix AL; Coria F; Clavería LE
    Ann Pharmacother; 1993 Jan; 27(1):101-2. PubMed ID: 8431609
    [No Abstract]   [Full Text] [Related]  

  • 3. Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge.
    Gray NS
    Hum Psychopharmacol; 2004 Apr; 19(3):205-7. PubMed ID: 15079855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preface: Malignant syndrome in Parkinson's disease.
    Narabayashi H; Mizuno Y
    Parkinsonism Relat Disord; 2003 Apr; 9 Suppl 1():S1. PubMed ID: 12735908
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of methyprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease.
    Clarke CE
    J Neurol Neurosurg Psychiatry; 2004 Mar; 75(3):510-1; author reply 511. PubMed ID: 14966183
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatal neuroleptic malignant syndrome induced by clozapine in Parkinson's psychosis.
    Mesquita J; Siva L
    J Neuropsychiatry Clin Neurosci; 2014; 26(1):E34. PubMed ID: 24515703
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neuroleptic malignant syndrome after aortic valve replacement; report of a case].
    Ichiba T; Takemoto N
    Kyobu Geka; 2003 Sep; 56(10):872-4. PubMed ID: 13677924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A case of Parkinson's disease with neuroleptic malignant syndrome induced by paroxetine].
    Hamada Y; Miyamoto K; Inatsugi Y; Suzuki H; Kusunoki S
    Rinsho Shinkeigaku; 2006 Aug; 46(8):575-8. PubMed ID: 17154040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levodopa withdrawal syndrome identical to neuroleptic malignant syndrome.
    Gibb WR; Griffith DN
    Postgrad Med J; 1986 Jan; 62(723):59-60. PubMed ID: 3797365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clozapine for drug-induced psychosis in Parkinson's disease.
    Brown TM
    N Engl J Med; 1999 Aug; 341(6):456. PubMed ID: 10438274
    [No Abstract]   [Full Text] [Related]  

  • 12. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH; Feinberg SS; Feldman RG
    JAMA; 1985 Nov; 254(19):2792-5. PubMed ID: 4057489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case report: cold medicines cause neuroleptic malignant-like syndrome in a patient with Parkinson's disease.
    JiYi X; Hantao S; Lijiao Z; Bin Q
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1203-1204. PubMed ID: 35419677
    [No Abstract]   [Full Text] [Related]  

  • 15. An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay.
    Bonnici A; Ruiner CE; St-Laurent L; Hornstein D
    Ann Pharmacother; 2010 Sep; 44(9):1504-7. PubMed ID: 20628041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum iron and neuroleptic malignant syndrome.
    Gurrera RJ
    Am J Psychiatry; 1991 Oct; 148(10):1405-6. PubMed ID: 1897629
    [No Abstract]   [Full Text] [Related]  

  • 17. Iron in neuroleptic malignant syndrome.
    Turner E; Reddy H
    Lancet; 1991 Sep; 338(8770):820-1. PubMed ID: 1681186
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroleptic malignant-like syndrome and lithium.
    Koehler PJ; Mirandolle JF
    Lancet; 1988 Dec 24-31; 2(8626-8627):1499-500. PubMed ID: 2904622
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Mizuta E; Yamasaki S; Nakatake M; Kuno S
    Neurology; 1993 May; 43(5):1048-9. PubMed ID: 7605396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome without withdrawal of levodopa.
    Singla R; Singla A; Kumar S; Kar P
    Natl Med J India; 2009; 22(3):162. PubMed ID: 19764697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.